USA

iShares Evolved U.S. Healthcare Staples ETF

The iShares Evolved U.S. Healthcare Staples ETF (the “Fund”) seeks to provide access to U.S. companies with healthcare staples exposure, as classified using a proprietary classification system.

$41.40

Key Metrics

TER 18.00% per year
Distribution policy Accumulating
Fund size USD 39 M
Inception date March 21, 2018
Holdings 167
Fund currency USD
Fund domicile US
Provider iShares

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Evolved U.S. Healthcare Staples ETF IEHS
Fund Size
$38.8M
Dividend
-
Fees
18.00%
Core S&P 500 ETF IVV
Fund Size
$722B
Dividend
1.1%
Fees
3.00%
Core U.S. Aggregate Bond ETF AGG
Fund Size
$146B
Dividend
4.0%
Fees
3.00%
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPYM
Fund Size
$118B
Dividend
1.0%
Fees
2.00%
Schwab U.S. Dividend Equity ETF SCHD
Fund Size
$86B
Dividend
3.3%
Fees
6.00%
View 419 similar ETFs →

Historical Return

Last updated: Jun 15, 2026
1 Year N/A
3 Years (avg.) N/A
5 Years (avg.) +0.3%

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

N/A 1 Year
N/A 3 Years
10.88% 5 Years
17.55% 10 Years

Max Drawdown

N/A 1 Year
N/A 3 Years
-21.27% 5 Years
-33.17% 10 Years

Sharpe Ratio

N/A 1 Year
N/A 3 Years
-0.29 5 Years
0.32 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026
2018 2019 2020 2021 2022
2018 6.9% 15.3% 15.8% 17.4% 11.6%
2019 24.2% 20.4% 21.1% 12.8%
2020 16.8% 19.5% 9.3%
2021 22.3% 5.7%
2022 -8.7%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%
6%
1y 3y N/A N/A
0 - 5%
34%
1y 3y N/A N/A
5 - 10%
12%
1y 3y N/A N/A
10 - 15%
24%
1y 3y N/A N/A
15 - 20%
12%
1y 3y N/A N/A
20 - 30%
11%
1y 3y N/A N/A
30 - 40%
0%
1y 3y N/A N/A
> 40%
0%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
6%
1y 3y N/A N/A
0 - 10
1%
1y 3y N/A N/A
10 - 15
4%
1y 3y N/A N/A
15 - 20
8%
1y 3y N/A N/A
20 - 25
18%
1y 3y N/A N/A
25 - 35
38%
1y 3y N/A N/A
35 - 50
18%
1y 3y N/A N/A
> 50
8%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.3%
1y 3y N/A N/A
Small Cap
1.9%
1y 3y N/A N/A
Mid Cap
5.5%
1y 3y N/A N/A
Large Cap
66.9%
1y 3y N/A N/A
Mega Cap
25.4%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jun 15, 2026
39.1% Top 5 Holdings
56.6% Top 10 Holdings
91.2% Top 50 Holdings
98.1% Top 100 Holdings
Top 5 Companies
UNH Unitedhealth Group Inc
16.9%
ABT Abbott Laboratories
7.6%
DHR Danaher Corp.
5.2%
JNJ Johnson & Johnson
4.8%
MDT Medtronic Plc
4.6%

Latest News

12 days ago • prnewswire.com

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

Patients in the IMAAVY 30 mg/kg treatment group a achieved statistically significant durable hemoglobin response b , with mean hemoglobin improveme...

13 days ago • 247wallst.com

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

I keep buying NVIDIA, Eli Lilly, and Johnson & Johnson, and if a fire took my brokerage statement to zero tomorrow, those are the three tickers I w...

13 days ago • 247wallst.com

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Ten thousand dollars a month in dividend income works out to $120,000 per year. That is enough to cover the rent on a luxury waterfront condo in Mi...

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $175B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.48% 2.03%
Beta Indicates the relationship between the price performance of a share and the market. 0.75 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 34.9 28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -21.32 -
Profitable Companies 94% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 39.3 14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 3.74 8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 6.33 10.72
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 24.56 21.15
Enterprise Value to Revenue Enterprise value divided by revenue 3.91 8.72
Total Debt to Enterprise Value Total debt divided by enterprise value 0.17 0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.65 0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 9.42% -6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -3.7% -117.9%
Return on Equity Equity divided by market cap. 12.38% 1.23%
Return on Assets Indicates a company's profitability in relation to its total assets. 5.22% 3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 10.05% 3.31%

Sectors

Manufacturing 50.1%
Finance and Insurance 24.8%
Health Care and Social Assistance 6.7%
Professional, Scientific, and Technical Services 5.6%
Retail Trade 3.9%
Wholesale Trade 2.5%
Healthcare 2.1%
Information 0.2%
Educational Services 0.1%
Construction 0.1%
Utilities 0.0%
Administrative and Support and Waste Management and Remediation Services 0.0%
Other 3.9%

Countries

Other 100.0%
United States 0.0%

Stock Screener

Select filters to narrow down the 154 investments below

154 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $364.13B
P/E Ratio 30.3
Dividends 2.2%
Total Investment $6.3M
Weight 16.24%

Loading details…

Market Cap $153.94B
P/E Ratio 24.6
Dividends 2.8%
Total Investment $2.83M
Weight 7.30%

Loading details…

Market Cap $125.4B
P/E Ratio 34.1
Dividends 0.8%
Total Investment $1.93M
Weight 4.99%

Loading details…

Market Cap $549.78B
P/E Ratio 26.5
Dividends 2.3%
Total Investment $1.8M
Weight 4.64%

Loading details…

Market Cap $101.86B
P/E Ratio 21.2
Dividends 3.6%
Total Investment $1.71M
Weight 4.42%

Loading details…

Loading details…

Market Cap $114.59B
P/E Ratio 16.5
Dividends 1.8%
Total Investment $1.28M
Weight 3.31%

Loading details…

Market Cap $125.45B
P/E Ratio 42.6
Dividends 2.7%
Total Investment $1.27M
Weight 3.29%

Loading details…

Market Cap $382.74B
P/E Ratio 106.2
Dividends 3.1%
Total Investment $1.21M
Weight 3.12%

Loading details…

Market Cap $144.07B
P/E Ratio 48.6
Dividends 0.0%
Total Investment $1.2M
Weight 3.10%

Loading details…

Market Cap $118B
P/E Ratio 35.3
Dividends 1.1%
Total Investment $999.45K
Weight 2.58%

Loading details…

Market Cap $52.16B
P/E Ratio 36.5
Dividends 2.6%
Total Investment $916.9K
Weight 2.36%

Loading details…

Market Cap $50.3B
P/E Ratio 46.2
Dividends 0.0%
Total Investment $876.81K
Weight 2.26%

Loading details…

Market Cap $175.45B
P/E Ratio 18.9
Dividends 0.0%
Total Investment $815.13K
Weight 2.10%

Loading details…

Market Cap $73.88B
P/E Ratio 11.8
Dividends 2.2%
Total Investment $760.82K
Weight 1.96%

Loading details…

Market Cap $43.3B
P/E Ratio 38.4
Dividends 1.0%
Total Investment $733.6K
Weight 1.89%

Loading details…

Market Cap $83.23B
P/E Ratio 12.8
Dividends 0.8%
Total Investment $694.4K
Weight 1.79%

Loading details…

Market Cap $30.13B
P/E Ratio -4.7
Dividends 0.0%
Total Investment $637.5K
Weight 1.64%

Loading details…

Market Cap $87.88B
P/E Ratio 19.2
Dividends 0.4%
Total Investment $459.77K
Weight 1.19%

Loading details…

Market Cap $27.36B
P/E Ratio 18.2
Dividends 1.3%
Total Investment $452.18K
Weight 1.17%

Loading details…